Navigation Links
PointCross Life Sciences Opens New Office in Silver Spring, Maryland for Data Standardization of Nonclinical Studies
Date:7/9/2013

FOSTER CITY, Calif., July 9, 2013 /PRNewswire/ -- Extending its recently announced Data Standardization Service, PointCross Life Sciences announced that it has opened a new center in Silver Spring, MD, USA where studies submitted by sponsors to the FDA in PDF and other formats will be standardized to fit into the Agency's NIMS (Nonclinical Information Management System) environment.  Increased access to such structured study data combined with computational review tools in NIMS are aligned with the Agency's goals of integrating regulatory history into scientific information and advancing regulatory science research.

(Logo: http://photos.prnewswire.com/prnh/20120327/AQ77258LOGO)

The PointCross team in the Maryland center applies the same methodology, processes, computational tools and information security controls used by other centers at PointCross Life Sciences.  It will focus on standardization of studies already submitted to the FDA. 

New studies that require extensions to the NIMS data model to handle novel protocols, innovative studies and new study types will be modeled and provided to the FDA.

About PointCross Life Sciences, Inc.

PointCross Life Sciences, Inc. is a global provider of Big Data analytics, data store and translational informatics solutions and Data Standardization Services designed for large, complex, and weakly structured datasets.  Our offerings are used by researchers and reviewers involved with drug development, and are available behind the Enterprise firewall or on the Cloud.  Our clients include several global Biopharma companies and the FDA.  The FDA's NIMS solution is based on PointCross' DSIMS platform.  PointCross Life Sciences is a wholly owned subsidiary of PointCross, Inc.

Contact
Dr. Shree Nath, Vice President
PointCross Life Sciences, Inc. 
1291 E. Hillsdale Blvd., Suite 304
Foster City, CA 94404 
1-866-468-1900 or shree@pointcross.com
www.pointcrosslifesciences.com


'/>"/>
SOURCE PointCross Life Sciences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Flagship Biosciences Introduces a New Technique for Measuring Fibrosis in Nonalcoholic Steatohepatitis
2. Islet Sciences, Inc. Technologies Featured in Five Separate Presentations at the American Diabetes Association Annual Meeting
3. Accel-KKR Makes Growth Equity Investment in Zinc Ahead, Leading Provider of Marketing Compliance Solutions for the Life Sciences Industry
4. Pfizer, GSK, and Siemens Form R&D Consortium With A*STARs Institute of Chemical & Engineering Sciences
5. NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI
6. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
7. Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding
8. Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit
9. IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
10. MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors
11. BioDelivery Sciences Announces NDA Submission for BUNAVAIL on Track Following Positive Pre-NDA Meeting with FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2018)... ... September 24, 2018 , ... ReGrow Helmet , the ... quality and most affordable option for hair regrowth in the comfort of one’s home. ... October 2, 2018. , The sophisticated design and advanced technology of the ReGrow ...
(Date:9/22/2018)... and WESTMINSTER, Colo. (PRWEB) , ... ... ... and Flagship Biosciences are excited to announce a strategic venture. The synergistic ... digital pathology platform provides complimentary and comprehensive biomarker profiling to empower clinical ...
(Date:9/22/2018)... ... September 20, 2018 , ... ... solutions for drugs, biologics and consumer health products, today announced that it will ... Drug Delivery in Modern Pharmaceutical Development,”. The one-day event is to be held ...
(Date:9/22/2018)... ... September 21, 2018 , ... ... phenotypes in tissue function, development, and pathogenesis requires tools that can rapidly ... , Multiplexed Ion Beam Imaging by Time-Of-Flight (MIBI-TOF) detects elements from ...
Breaking Biology Technology:
(Date:9/24/2018)... (PRWEB) , ... September 24, 2018 , ... ... announced that the team will be exhibiting at the Society for Clinical Data ... 2018. The team will also be participating at DPHARM: Disruptive Innovations in Boston, ...
(Date:9/24/2018)... ... September 24, 2018 , ... Hepatitis D virus ... (HBsAg) to infect the hepatocytes. Chronic Hepatitis D is recognized as the most ... carcinoma and a high mortality rate. , HDV infection affects an estimated ...
(Date:9/24/2018)... ... September 24, 2018 , ... Energetiq ... is pleased to announce that starting on October 1, 2018 Hamamatsu will distribute ... 2017. , “We have been working steadfastly since our acquisition to integrate with ...
Breaking Biology News(10 mins):